A new Centers for Disease Control and Prevention report offers guidance on the preexposure use of the JYNNEOS smallpox and monkeypox vaccine for individuals at risk for occupational exposure to orthopoxviruses. The recommendations were made by the CDC’s Advisory Committee on Immunization Practices. The committee recommends preexposure vaccination for people who work in laboratories doing research on orthopoxviruses; people who work in clinical laboratories performing testing to diagnose orthopoxviruses, certain people responding to orthopoxvirus-related public health investigations; and health care personnel who care for patients infected with orthopoxviruses or administer the ACAM2000 vaccine.

Related News Articles

Headline
The Centers for Disease Control and Prevention June 30 released guidance for all laboratories that perform diagnostics testing for monkeypox. The guidance…
Headline
 The Administration plans to immediately allocate 56,000 doses of JYNNEOS monkeypox vaccine from the Strategic National Stockpile to states and…
Headline
To increase monkeypox testing capacity during the U.S. outbreak, the Centers for Disease Control and Prevention yesterday began shipping orthopoxvirus…
Headline
The Centers for Disease Control and Prevention and Florida Department of Health are investigating at least 24 cases of meningococcal disease, including seven…
Headline
Federal agencies have updated their guidance for handling Category A solid waste, including waste that may be contaminated with monkeypox virus, the…
Headline
The Centers for Disease Control and Prevention yesterday updated its guidance to help clinicians evaluate and test patients with relevant history, signs and…